We are live on ! Find out more
AIM

ARK Investment Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 64.92%
 

ARK Investment Management LLC, founded in 2014 by Cathie Wood and headquartered in St. Petersburg, Florida, is an investment firm managing over $15 billion in assets as of late 2024, renowned for its focus on disruptive innovation across thematic equity ETFs. With a mission to invest in technologies shaping the future, ARK targets five key areas—artificial intelligence, genomics, autonomous technology, energy storage, and blockchain—offering funds like the ARK Innovation ETF (ARKK) to retail and institutional investors seeking high-growth opportunities. Wood, a former AllianceBernstein economist, leads a team of about 50, emphasizing active management, deep research, and a long-term horizon, often holding volatile, speculative stocks like Tesla and Coinbase, which fueled massive gains in 2020 but faced challenges in 2022’s bear market. Known for its transparent, educational approach—including daily portfolio disclosures and bold predictions like Bitcoin reaching $1 million—ARK has carved a niche as a forward-thinking, risk-embracing player in the investment landscape.

This Fund
S&P 500
This Quarter Est. Return
+13.58%
1 Year Est. Return
+64.92%
3 Year Est. Return
+195.95%
5 Year Est. Return
+58.35%
10 Year Est. Return
AUM
$514M
AUM Growth
+$167M
Cap. Flow
+$120M
Cap. Flow %
23.3%
Top 10 Hldgs %
38.85%
Holding
110
New
6
Increased
94
Reduced
9
Closed
1

Top Sells

Rank Stock Value
1
ATHN
Athenahealth, Inc.
ATHN
+$4.09M
2
SSYS icon
Stratasys
SSYS
+$3.33M
3
ILMN icon
Illumina
ILMN
+$2.86M
4
IBM icon
IBM
IBM
+$2.84M
5
SCHW
Charles Schwab
SCHW
+$2.55M

Sector Composition

Rank Sector Weight
1 Technology 27.83%
2 Healthcare 18.6%
3 Communication Services 14.82%
4 Industrials 12.56%
5 Consumer Discretionary 12.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLNX
76
DELISTED
Mellanox Technologies, Ltd.
MLNX
$608K 0.12%
14,037
+6,955
+98% +$330K
REGN icon
77
Regeneron Pharmaceuticals
REGN
$78.5B
$606K 0.12%
1,234
+544
+79% +$238K
GM icon
78
General Motors
GM
$80.4B
$588K 0.11%
16,827
-8,637
-34% -$293K
ROK icon
79
Rockwell Automation
ROK
$53.4B
$552K 0.11%
3,409
+1,109
+48% +$175K
AGIO icon
80
Agios Pharmaceuticals
AGIO
$1.79B
$551K 0.11%
10,713
+4,267
+66% +$218K
INO icon
81
Inovio Pharmaceuticals
INO
$55.7M
$517K 0.1%
5,492
+2,428
+79% +$208K
INCY icon
82
Incyte
INCY
$24.2B
$492K 0.1%
3,911
+2,469
+171% +$314K
BOX icon
83
Box
BOX
$4.37B
$470K 0.09%
25,765
+13,685
+113% +$247K
UCTT
84
Ultra Clean Holdings
UCTT
$3.73B
$461K 0.09%
24,560
+6,046
+33% +$122K
FPRX
85
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$427K 0.08%
14,174
+10,623
+299% +$332K
ALNY icon
86
Alnylam Pharmaceuticals
ALNY
$27.5B
$421K 0.08%
5,276
-948
-15% -$60.6K
UPS icon
87
United Parcel Service
UPS
$88.6B
$409K 0.08%
3,695
+1,699
+85% +$182K
PLUG icon
88
Plug Power
PLUG
$2.87B
$397K 0.08%
+194,433
New +$407K
AME icon
89
Ametek
AME
$55.4B
$375K 0.07%
6,184
+2,293
+59% +$135K
HWM icon
90
Howmet Aerospace
HWM
$113B
$374K 0.07%
21,536
+7,577
+54% +$154K
FARO
91
DELISTED
Faro Technologies
FARO
$373K 0.07%
9,870
+4,569
+86% +$162K
PI icon
92
Impinj
PI
$4.62B
$285K 0.06%
+5,864
New +$246K
SYRS
93
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$285K 0.06%
1,771
+946
+115% +$149K
ADBE icon
94
Adobe
ADBE
$99.5B
$267K 0.05%
1,890
+1,003
+113% +$137K
SHOP icon
95
Shopify
SHOP
$152B
$242K 0.05%
+27,880
New +$236K
CELG
96
DELISTED
Celgene Corp
CELG
$208K 0.04%
1,599
+704
+79% +$86.3K
CRSP icon
97
CRISPR Therapeutics
CRSP
$4.73B
$206K 0.04%
+12,888
New +$213K
NNDM
98
Nano Dimension
NNDM
$316M
$167K 0.03%
2,732
+1,399
+105% +$89.1K
JNCE
99
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$167K 0.03%
11,932
+10,121
+559% +$217K
CLLS
100
Cellectis
CLLS
$277M
$104K 0.02%
4,038
+1,784
+79% +$42.6K

Similar funds

ARK Investment Management's Q2 2017 Portfolio in Review

As of Q2 2017, ARK Investment Management held 110 positions worth $514M, up 48% from $347M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

ARK Investment Management deployed $120M of net new capital in Q2 2017, opening 6 new positions and adding to 94 existing holdings. Its largest new stake was Intuit: 17,139 shares worth $2.28M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Athenahealth, Inc., an estimated $4.09M trimmed.

  • ARK Investment Management's largest Q2 2017 buy was Intuit: 17,139 shares worth $2.28M.
  • ARK Investment Management added most to Amazon in Q2 2017, an estimated $7.94M increase.
  • ARK Investment Management's biggest Q2 2017 reduction was Athenahealth, Inc., cutting an estimated $4.09M.
  • ARK Investment Management fully exited Charles Schwab in Q2 2017, selling an estimated $2.55M.
  • ARK Investment Management's ten largest holdings make up 39% of its $514M portfolio in Q2 2017.
  • ARK Investment Management opened 6 new positions and closed 1 in Q2 2017.
  • ARK Investment Management's portfolio value rose 48% quarter-over-quarter to $514M.

Based on ARK Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.